Literature DB >> 32377932

Animal-to-Human Viral Transitions: Is SARS-CoV-2 an Evolutionarily Successful One?

Konstantinos Voskarides1.   

Abstract

Transmission of viruses from one species to another is not unusual in nature. Despite this, evolutionarily successful transmissions are rare. Such events can cause pandemics and are followed by host-virus coevolution procedures that can increase the fitness potential of viruses. In this perspective article, I recognize eight main types of trans-species viral transmission. I consider two of them as evolutionarily successful, explaining why coronavirus SARS-CoV-2 could be one of them.

Entities:  

Keywords:  COVID-19; Epidemic; Gene; Infection; Molecular evolution; Mutation; Natural selection

Mesh:

Year:  2020        PMID: 32377932      PMCID: PMC7201112          DOI: 10.1007/s00239-020-09947-z

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


Transmission of viruses from one species to another is not unusual in nature. Focusing on humans, many people all over the world are in close proximity to animals due to local customs or due to their way of life. One can suppose that single transmission events of animal viruses to humans (viral exposure in human bodies/cells by direct contact) are happening daily, on the order of millions of times. The vast majority of those events are not successful in causing infection. It takes 100s or 1000s of years for a virus to “gain” the right combination of mutations in order to insert in human cells and survive further through spreading in multiple individuals (Longdon et al. 2014). Alternatively, it is just a matter of poor lack, the right virus at the right time to transit to a new host. Newly emerged viruses need an appropriate host cell receptor, ability to proliferate in the cytoplasm, and a way to escape host immunity (Llorente García and Marsh 2020). Thinking evolutionarily, natural selection favors: viruses that successfully infect host’s cells, viruses that are minimally lethal, viruses that are highly contagious (Plauzolles et al. 2015). Maybe the most known examples of such cases in humans are the viruses causing the seasonal common colds (Greenberg 2016). On the other hand, emergence of successful viruses is a rare event. Rare but it happens, since millions of mutations and infections (or transmissions) are happening every day. Pandemic phenomena could be the first presentation of trans-species infections. Through pandemic events, viruses can increase their fitness and become minimally harmful (see below for explanation). SARS-CoV-2 (Huang et al. 2020) may be an example of an evolutionary successful transition. Perhaps, we are all now witnesses of the first manifestations of this virus–host coevolution. Let’s now see what types of animal-to-human viral transmissions are possible. This is my personal view, under the concept of fitness and evolution. I recognize eight main possibilities, all are represented in Fig. 1: (1A) most animal–human contacts (millions or billions per day) do not result in any viral transmission. The most common reason is the absence of an appropriate receptor in human cells; thus, the virus will be destroyed by the human immune system; (1B) some animal viruses can occasionally infect humans, but symptoms are mild or none. Human-to-human transmission probability is limited or zero. Due to the characteristics of these infections, most of them are unknown to scientists; (1C) some animal viruses can occasionally infect humans, but symptoms are severe, even lethal. Human-to-human transmission probability is limited or zero (e.g., Rabies virus) (Brunker et al. 2018); (1D) these viral transitions are characterized by mild infections and low probability for human-to-human transmission (e.g., cowpox virus) (Pastoret et al. 2000); (1E) this type is similar with 1D, but the difference is that a percentage of the infections are lethal. The fatality percentage varies, depending on the viral species or strain (eg. MERS virus) (Zumla et al. 2015); (1F) this type is characterized by high probability for human-to-human transmission and mild infections (e.g., corona viruses causing common colds in humans, see below); (1G) this type is characterized by high probability for human-to-human transmission and high fatality rate (e.g., Ebola virus) (Malvy et al. 2019); and (1H) this type is characterized by high probability for human-to-human transmission and low fatality rate (e.g., SARS-CoV-2).
Fig. 1

Animal to human viral transition types. See details in text

Animal to human viral transition types. See details in text According to this classification, we could categorize SARS-CoV-2 as type 1H. In fact, we can consider that 1F and 1H are the most evolutionary successful viruses. SARS-CoV-2 is extremely contagious but fatality rate is low, around 3% (World Health Organization, March 3, 2020). If humans fail to eliminate this virus through vaccinations, then its fitness could be increased through years, its fatality rate will probably be reduced further, and we will finally have a type 1F virus. This could happen since many people that are genetically predisposed for severe infections will die and the genetic pool of human populations will be modified accordingly. This is the usual way that viruses increase their fitness (Fumagalli et al. 2010). Successful animal-to-human transitions are rare events. Focusing on corona viruses, there are four known corona viruses that cause mild infections in humans (originated through animal-to-human transition events): HCoV-229E, HCoV-OC43, HCoV-HKU1, and HCoV-NL63 (Ye et al. 2020; Vijaykrishna et al. 2007). These four viruses are not older than 150 years (Ye et al. 2020; Vijaykrishna et al. 2007). SARS-CoV-2 may become the fifth one, if finally, it will be established in the human populations. Corona viruses seem to transit relatively easily from animals to humans, but they also disappear easily through evolutionary time. We can assume that from the fact that modern humans have been evolved the last 120–150 thousand years (Poznik et al. 2013). It is not clear why evolutionary successful viruses disappear from host populations. Two possible explanations are genetic decay of viruses’ genomes though mutation accumulation or some large-scale extinctions of host populations. We presently know only five corona viruses (including SARS-CoV-2) that have been successfully spread in human populations for the last 150 years. Obviously, coronaviruses like MERS (Zumla et al. 2015) and SARS-CoV-1 (Peiris et al. 2003) did not ever reach a fitness threshold in order to be established in human populations. Of course, human population and population density are increasing in Earth, so probabilities for successful transitions/transmissions are increasing even more. The outbreak of SARS-CoV-2 reminded scientists of the need to learn more about the evolution of zoonotic diseases. The current pandemic can be a great opportunity to watch in real time the ongoing evolution of a probably evolutionarily successful animal-to-human viral transition. This is a valuable experience and a great source of knowledge for evolutionary biologists.
  14 in total

Review 1.  Genomic sequencing, evolution and molecular epidemiology of rabies virus.

Authors:  K Brunker; S Nadin-Davis; R Biek
Journal:  Rev Sci Tech       Date:  2018-08       Impact factor: 1.181

Review 2.  Ebola virus disease.

Authors:  Denis Malvy; Anita K McElroy; Hilde de Clerck; Stephan Günther; Johan van Griensven
Journal:  Lancet       Date:  2019-02-15       Impact factor: 79.321

3.  Evolutionary insights into the ecology of coronaviruses.

Authors:  D Vijaykrishna; G J D Smith; J X Zhang; J S M Peiris; H Chen; Y Guan
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

Review 4.  Influence of host resistance on viral adaptation: hepatitis C virus as a case study.

Authors:  Anne Plauzolles; Michaela Lucas; Silvana Gaudieri
Journal:  Infect Drug Resist       Date:  2015-04-07       Impact factor: 4.003

Review 5.  The evolution and genetics of virus host shifts.

Authors:  Ben Longdon; Michael A Brockhurst; Colin A Russell; John J Welch; Francis M Jiggins
Journal:  PLoS Pathog       Date:  2014-11-06       Impact factor: 6.823

Review 6.  Middle East respiratory syndrome.

Authors:  Alimuddin Zumla; David S Hui; Stanley Perlman
Journal:  Lancet       Date:  2015-06-03       Impact factor: 79.321

7.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 8.  Update on Human Rhinovirus and Coronavirus Infections.

Authors:  Stephen B Greenberg
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

Review 9.  A biophysical perspective on receptor-mediated virus entry with a focus on HIV.

Authors:  Isabel Llorente García; Mark Marsh
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-12-19       Impact factor: 3.747

Review 10.  Zoonotic origins of human coronaviruses.

Authors:  Zi-Wei Ye; Shuofeng Yuan; Kit-San Yuen; Sin-Yee Fung; Chi-Ping Chan; Dong-Yan Jin
Journal:  Int J Biol Sci       Date:  2020-03-15       Impact factor: 6.580

View more
  4 in total

Review 1.  Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2?

Authors:  Beatriz do Vale; Ana Patrícia Lopes; Maria da Conceição Fontes; Mário Silvestre; Luís Cardoso; Ana Cláudia Coelho
Journal:  Vet Res Commun       Date:  2021-01-19       Impact factor: 2.459

Review 2.  SARS-CoV-2: tracing the origin, tracking the evolution.

Authors:  Konstantinos Voskarides
Journal:  BMC Med Genomics       Date:  2022-03-18       Impact factor: 3.063

Review 3.  Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2.

Authors:  Rim Jbeli; Awatef Jelassi
Journal:  EuroMediterr J Environ Integr       Date:  2021-07-04

4.  Large-scale study on virological and serological prevalence of SARS-CoV-2 in cats and dogs in Spain.

Authors:  Sandra Barroso-Arévalo; Alberto Barneto; Ángel Manuel Ramos; Belén Rivera; Rocío Sánchez; Lidia Sánchez-Morales; Marta Pérez-Sancho; Aránzazu Buendía; Elisa Ferreras; Juan Carlos Ortiz-Menéndez; Inmaculada Moreno; Consuelo Serres; Carmen Vela; María Ángeles Risalde; Lucas Domínguez; José M Sánchez-Vizcaíno
Journal:  Transbound Emerg Dis       Date:  2021-11-16       Impact factor: 4.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.